A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 284
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PLA2R
Long Form : phospholipase A2 receptor
No. Year Title Co-occurring Abbreviation
2022 A case of Gitelman syndrome with membranous nephropathy. GS, MN, NS, SLT
2022 A Case of M-Type Phospholipase A2 Receptor-Associated Membranous Nephropathy With IgG4-Positive Cells Infiltration in the Interstitium. IgG4-RKD, MN
2022 A Case of Membranous Nephropathy Hypothesized to be Associated With COVID-19 Vaccine. COVID-19, MN
2022 Anti-phospholipase A2 receptor antibodies directly induced podocyte damage in vitro. MN
2022 Anti-Phospholipase A2 Receptor Antibodies in Biopsy-Proven Idiopathic Membranous Nephropathy: A Report from the Pakistani Population. ---
2022 Anti-Phospholipase A2 Receptor Antibody Expression at Different Stages of Idiopathic Membranous Nephropathy. IMN
2022 Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathy. Chol, LDL, PMN
2022 Association of serum mannose-binding lectin, anti-phospholipase A2 receptor antibody and renal outcomes in idiopathic membranous nephropathy and atypical membranous nephropathy: a single center retrospective cohort study. aMN, IMN, MBL
2022 Case Report: Successful treatment of late-onset immune checkpoint inhibitor-associated membranous nephropathy in a patient with advanced renal cell carcinoma. AKI, ICI, irAE, MN, RCC, THSD7A
10  2022 Characteristics and renal survival of patients with lupus nephritis with glomerular immunoglobulin G4 deposition: a single-centre retrospective analysis. LN, RR, SLEDAI
11  2022 Clinical Evaluation of Antiphospholipase A2 Receptor IgG4 level and Its IgG4-to-IgG Ratio Based on Quantitative Immunoassays in Idiopathic Membranous Nephropathy. IMN
12  2022 Clinicopathological Characteristics and Outcomes of PLA2R-Associated Membranous Nephropathy in Seropositive Patients Without PLA2R Staining on Kidney Biopsy. CR, eGFR, MN, PR
13  2022 Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome? IgAN, MN
14  2022 Critical evaluation of cancer risks in glomerular disease. IgG, MN, NELL-1, THSD7A
15  2022 Efficacy and Safety of Different Immunosuppressive Therapies in Patients With Membranous Nephropathy and High PLA2R Antibody Titer. CR, KDIGO, MN, TAC, TR
16  2022 Favorable outcome in PLA2R positive HBV-associated membranous nephropathy. HBV-MN, iMN
17  2022 Hypercholesterolemia Correlates With Glomerular Phospholipase A2 Receptor Deposit and Serum Anti-Phospholipase A2 Receptor Antibody and Predicts Proteinuria Outcome in Idiopathic Membranous Nephropathy. HR, IMN, LDL-C, non-HDL-C, OR, TC, TG
18  2022 Intrarenal Single-Cell Sequencing of Hepatitis B Virus Associated Membranous Nephropathy. DEGs, ECs, GO, GSVA, HBV, IMN, MN, scRNA-seq
19  2022 Malignancy-Associated Membranous Nephropathy with Positive Anti-PLA2R Autoantibodies: Coincidence or Connection. MN
20  2022 Novel Biomarkers in Membranous Nephropathy. ESRD, MN, MS, ncRNAs, NS
21  2022 Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature. aHUS, TMA
22  2022 Prevalence of neural epidermal growth factor-like 1- and exostosin 1/exostosin 2-associated membranous nephropathy: a single-center retrospective study in Japan. MN, NELL-1, SEMA3B, THSD7A
23  2022 Recent Advances in Clinical Diagnosis and Pharmacotherapy Options of Membranous Nephropathy. MN, THSD7A
24  2022 Revisiting immunological and clinical aspects of membranous nephropathy. IMN, MAC, THSD7A
25  2022 Secretory expression and purification of recombinant PLA2R epitopes for the detection of anti-PLA2R autoantibody in serum. IMN
26  2022 Structure of PLA2R reveals presentation of the dominant membranous nephropathy epitope and an immunogenic patch. ---
27  2022 The Efficacy of an Initial Prednisone Monotherapy Regimen on PLA2R-associated Idiopathic Membranous Nephropathy. IMN
28  2022 Treatment resistant M-type phospholipase A2 receptor associated membranous nephropathy responds to obinutuzumab: a report of two cases. IR, MN, NS
29  2022 VEGFA promotes the occurrence of PLA2R-associated idiopathic membranous nephropathy by angiogenesis via the PI3K/AKT signalling pathway. BV, DEGs, GBM, GEO, GSEA, HVECs, IMN, PHN, VEGFA
30  2022 [Clinical Significance of IgG4 Level in Predicting the Activity and Outcome of Phospholipase A2 Receptor-associated Membranous Nephropathy]. IgAN, SMN
31  2022 [The 493th case: recurrent edema of bilateral lower extremeties]. ---
32  2021 A case report of breast cancer and membranous nephropathy with positive anti phospholipase A2 receptor antibodies. MN
33  2021 A conceptual framework linking immunology, pathology, and clinical features in primary membranous nephropathy. ---
34  2021 A Novel Insight into the Role of PLA2R and THSD7A in Membranous Nephropathy. MN, THSD7A
35  2021 A PLA2R-IgG4 Antibody-Based Predictive Model for Assessing Risk Stratification of Idiopathic Membranous Nephropathy. IMN, RF, TR-FIA
36  2021 Advances in antigens associated with Idiopathic Membranous Nephropathy. iMN, MN
37  2021 Advances in Pathogenesis of Idiopathic Membranous Nephropathy. HLA, IMN, MN, PLA2R1, THSD7A
38  2021 Calcineurin inhibitor therapy in combination with Tripterygium wilfordii polyglycoside tablets for idiopathic membranous nephropathy: A retrospective clinical observation. 24hUP, ALB, CNI, GCs, IMN, LDL-C, TG, TWPs
39  2021 Case Report: A Rare Presentation of NSAID-Induced Secondary Membranous Nephropathy in a Pediatric Patient. MN, NSAID
40  2021 Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection. 24h-TP, ALB, BUN, HBV, IMN, SCr, TCHO, TG, UA
41  2021 Combination of Rituximab, Low-Dose Cyclophosphamide, and Prednisone for Primary Membranous Nephropathy: A Case Series With Extended Follow Up. IQR, MN, UPCR
42  2021 Concurrent Anti-Glomerular Basement Membrane Antibody Disease and Membranous Nephropathy: A Case Series. ANCA, GBM, MN
43  2021 Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report. CNTN1, MN
44  2021 Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy. MCD, MN, NS
45  2021 Diagnostic performance of glomerular PLA2R and THSD7A antibodies in biopsy confirmed primary membranous nephropathy in South Africans. DN, PMN, PPV, THSD7A
46  2021 Effects of phospholipase A2 receptor and thrombospondin type-1 domain-containing 7A expression in glomerular basement membranes on treatment response and renal outcome in membranous nephropathy. MN, THSD7A
47  2021 Establishment and application of an immunoassay for the simultaneous detection of IgG and its subtype IgG4 autoantibodies against M-type phospholipase A2 receptor. IMN, MN, TR-FIA
48  2021 HLA Alleles and Prognosis of PLA2R-Related Membranous Nephropathy. ---
49  2021 How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy. MN
50  2021 Identification of a Locus on the X Chromosome Linked to Familial Membranous Nephropathy. GRSs, Mb, MN, NS
51  2021 Malignancy-associated membranous nephropathy with PLA2R double-positive for glomeruli and carcinoma. Ig, MN, RCC
52  2021 Mechanisms of Primary Membranous Nephropathy. CNTN1, EXT1, MN, PMN, THSD7A
53  2021 Membranous nephropathy associated with viral infection. HBV, HCV, HIV, MN, THSD7A, UPCR
54  2021 Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review. Ig, ITP, LDL-A, MN, U-PCR
55  2021 Membranous nephropathy. MN
56  2021 Membranous nephropathy: a single diseaseor a pattern of injury resulting from different diseases. GBM, MN, SE, THSD7A
57  2021 Monitoring anti-PLA2R antibody titres to predict the likelihood of spontaneous remission of membranous nephropathy. Ab, CI, MN, OR, PEP, SR
58  2021 Neural Epidermal Growth Factor-Like 1 Protein-Positive Membranous Nephropathy in Chinese Patients. NELL1, THSD7A
59  2021 Nivolumab-induced membranous nephropathy in a patient with stage IV lung adenocarcinoma. ICIs, irAEs, MN
60  2021 Pathophysiology, diagnosis, and treatment of membranous nephropathy. GBM, MN, THSD7A
61  2021 Perspectives in membranous nephropathy. MN, THSD7A
62  2021 Primary membranous glomerulonephritis with negative serum PLA2R in haemophilia A successfully managed with rituximab - case report and review of the literature. HCV, HIV, MN
63  2021 Primary Membranous Nephropathy With Enhanced Staining of Exostosin 1/Exostosin 2 in the Glomeruli: A Report of 2 Cases. EXT1, THSD7A
64  2021 Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway. Bax, Bcl-2, MN, mTOR, PI3K
65  2021 Rapid, quantitative, and high-sensitivity detection of anti-phospholipase A2 receptor antibodies using a novel CdSe/ZnS-based fluorescence immunosorbent assay. AUC-ROC, ELISA, IMN, QD-ICA, RU
66  2021 Retrospective analysis of Tripterygium wilfordii polyglycoside combined with angiotensin receptor blockers for the treatment of primary membranous nephropathy with sub-nephrotic proteinuria. ARB, CR, eGFR, PMN, TWG
67  2021 Rituximab in Membranous Nephropathy. MN
68  2021 Sjögren's syndrome complicated with membranous nephropathy, a cause or coincidence? MN, SLE, SS
69  2021 The association between variants in PLA2R and HLA-DQA1 and renal outcomes in patients with primary membranous nephropathy in Western China. HLA-DQA1, PMN, SNPs
70  2021 The correlation of anti-beta2-glycoprotein I antibody with complement activation in patients with idiopathic membranous nephropathy. anti-beta2GPI, IMN
71  2021 The Prevalence of Mesangial Electron-Dense Deposits in PLA2R-Positive Membranous Nephropathy. EM, IF, MN
72  2021 Treatment of exostosin 1-associated membranous lupus nephritis with multiple low doses of rituximab: A case report. LN, MN, THSD7A
73  2021 When the Donor Surprises You: A Case Report. KT, MN
74  2021 [Membranous nephropathy]. ---
75  2020 A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti-Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients. CKD, MBCs, MN, PhIP-Seq, TNF-alpha
76  2020 Antigens, antibodies, and membranous nephropathy: adecade of progress. MN
77  2020 Autoantibodies against phospholipase A2 receptor in Brazilian patients with glomerular diseases. Abs, MN
78  2020 Clinical significance of M-type phospholipase A2 receptor and thrombospondin Type 1 domain-containing 7A in primary membranous nephropathy. PMN, SMN, THSD7A
79  2020 Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods. ELISA, MN
80  2020 Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study. IMN
81  2020 Concomitant Nephrotic Syndrome with Diffuse Large B-cell Lymphoma: A Case Report. DLBCL, MN, NS
82  2020 Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy. ChLIA, ELISA, PMN, RC-IFA
83  2020 Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience. ELISA, IMN, RU
84  2020 Differential analysis of urinary albumin for membranous nephropathy patients by online capillary isoelectric focusing - Mass spectrometry. CIEF-MS, IMN, MN
85  2020 Efficacy of low or standard rituximab-based protocols and comparison to Ponticelli's regimen in membranous nephropathy. MN, pts, RTX, SCr
86  2020 Fumarate modulates phospholipase A2 receptor autoimmunity-induced podocyte injury in membranous nephropathy. MCD, MN
87  2020 Glomerular Diseases Associated with Malignancies: Histopathological Pattern and Association with Circulating Autoantibodies. ANA, ANCA, GD, MPO
88  2020 Identical twins with idiopathic membranous nephropathy. HLA
89  2020 Membranous Glomerulonephritis With Crescents. ANCAs, GBM, MGN, MPO, NCGN
90  2020 Membranous nephropathy in patients with HIV: a report of 11 cases. ARV, ESRD, HIV, MN
91  2020 Membranous Nephropathy in Pregnancy. PMN
92  2020 Membranous Nephropathy with Rapid Progression. anti-GBM
93  2020 Membranous nephropathy: A ten-year journey of discoveries. MN, THSD7A
94  2020 Meta-Analysis of the Diagnostic Efficiency of THSD7A-AB for the Diagnosis of Idiopathic Membranous Nephropathy. AUC, DOR, IMN, NLR, PLR, THSD7A
95  2020 Ofatumumab for multirelapsing membranous nephropathy complicated by rituximab-induced serum-sickness. MN, NS
96  2020 Phospholipase A2 Receptor Antibody-Positive Pregnancy: A Case Report. ---
97  2020 Phospholipase A2 Receptor Autoantibodies as a Novel Serological Biomarker for Autoimmune Thyroid Disease Associated Nephropathy. HT, IMN
98  2020 Podocyte Antigen Staining to Identify Distinct Phenotypes and Outcomes in Membranous Nephropathy: A Retrospective Multicenter Cohort Study. MN, NELL-1, THSD7A
99  2020 Profile of Indian Patients With Membranous Nephropathy. ELISA, MN, THSD7A
100  2020 Proteomic Analysis of Complement Proteins in Membranous Nephropathy. EXT1, EXT2, MN, MS/MS